Who to call at InnoCare Pharma, and when
Fundz watches for the moments InnoCare Pharma starts buying, and tells you who to reach.
- An alert the day InnoCare Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at InnoCare Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at InnoCare Pharma. With Fundz connected, it knows.
InnoCare Pharma enters a strategic research collaboration and licensing agreement with Eli Lilly to develop new medicines.
Contract Type
partnership
Description
InnoCare Pharma and Eli Lilly have announced a partnership aimed at developing new medicines, with potential payments reaching about $3.35 billion. Under the agreement, InnoCare will utilize its drug discovery platform for research against multiple targets.
Quick answer
InnoCare Pharma enters a strategic research collaboration and licensing agreement with Eli Lilly to develop new medicines. (September 24, 2026). InnoCare Pharma is based in Beijing, Beijing, China.
- What agreement did InnoCare Pharma announce on September 24, 2026?
- InnoCare Pharma and Eli Lilly have announced a partnership aimed at developing new medicines, with potential payments reaching about $3.35 billion. Under the agreement, InnoCare will utilize its drug discovery platform for research against multiple targets.
- What does InnoCare Pharma do?
- InnoCare Pharma is a leading biopharmaceutical company that focuses on the treatment of cancer and autoimmune diseases.
- Where is InnoCare Pharma based?
- InnoCare Pharma is based in Beijing, Beijing, China.
- Which similar companies announced agreements around the same time?
- YD Bio Limited (October 20, 2026), Alexion (October 29, 2026), AbbVie Inc. (November 3, 2026) and Hansoh Pharma (October 19, 2026) also announced agreements within 45 days of InnoCare Pharma.
Source: Fundz verified event record.
Other recent agreements in Medical and Therapeutics
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Hansoh Pharma and Roche Expand Partnership with $15 Billion Agreement for ADC Programs. (October 19, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
- Incyte and Genmab Form Partnership to Explore New Treatment for KRAS G12D-Mutated Metastatic Colorectal Cancer. (October 24, 2026)
Related People
Agreement Insights
What this usually meansInnoCare Pharma signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.